ZDF
Sign inSign up

Vulnerabilities

Vulnerability · CVE-2025-61940

NMIS/BioDose V22.02 and previous versions rely on a common SQL Server user account to access data in the database.

Published Dec 2, 2025 · catalog updated Dec 9, 2025 · Mirion Medical EC2 Software NMIS BioDose

Last checked Oct 27, 2026. A connected source was read within the last 7 days.

Check if you run it

No confirmed exploitation is on record for CVE-2025-61940. EPSS is 0.32%. Act only if a listed version of Mirion Medical EC2 Software NMIS BioDose is installed.

Gaps on this record

  • No vendor fix or required action is stored. Compare the linked advisory before you change production.

Same product and reporting

Severity
High8.7
Known exploitation
Not in CISA/VulnCheck KEV
EPSS
0.32%
Remediation
Version ranges on file
Affected products
vendor Mirion Medical EC2 Software NMIS BioDose 0 <23.0

NMIS/BioDose V22.02 and previous versions rely on a common SQL Server user account to access data in the database. User access in the client application is restricted by a password authentication check in the client software but the underlying database connection always has access. The latest version of NMIS/BioDose introduces an option to use Windows user authentication with the database, which would restrict this database connection.

Are you affected?

Enter the version you run. The result uses only the ranges stored on this record.

The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.

  • vendor Mirion Medical EC2 Software NMIS BioDose 0 <23.00 <23.0

How to fix CVE-2025-61940

What to do

Three questions, each answered from this record only. Confirm the vendor advisory before you patch.

Should you patch?

No confirmed exploitation is on record for CVE-2025-61940. EPSS is 0.32%. Act only if a listed version of Mirion Medical EC2 Software NMIS BioDose is installed.

Which versions are affected?

Compare what you have installed with Mirion Medical EC2 Software NMIS BioDose 0 <23.0 0 <23.0. Compare the installed version with the linked vendor advisory before you change production.

What should an analyst verify?

No weakness class is stored. EPSS 0.32%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.

Code

The project this record applies to. Exploit listings stay in References.

No public source repository is identified for this product.

Timeline

Detection, updates, and resolution for this record.

  1. Dec 2, 2025 · EUVD

    Detected

    NMIS/BioDose V22.02 and previous versions rely on a common SQL Server user account to access data in the database. User access in the client application is restricted by a password authentication check in the client software but the underlying database connection always has access. The latest version of NMIS/BioDose introduces an option to use Windows user authentication with the database, which w

  2. Dec 9, 2025 · EUVD

    Updated

    NMIS/BioDose V22.02 and previous versions rely on a common SQL Server user account to access data in the database. User access in the client application is restricted by a password authentication check in the client software but the underlying database connection always has access. The latest version of NMIS/BioDose introduces an option to use Windows user authentication with the database, which w

Sources

  • CVE.orgVulnerability recordCVE-2025-61940

    Official CVE identifier

    cve.org
  • FIRST EPSSExploitation probabilityCVE-2025-61940

    30-day exploitation probability 0.32%

    first.org
  • EUVDVulnerability recordEUVD-2025-200322

    NMIS/BioDose V22.02 and previous versions rely on a common SQL Server user account to access data in the database. User access in the client application is restricted by a password authentication check in the client software but the underlying database connection always has acces

    euvd.enisa.europa.eu

References

Freshness

Last verified in this catalog Oct 27, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.

  • CVE.orgOct 27, 2026
  • FIRST EPSSOct 27, 2026
  • EUVDOct 27, 2026